Uncover key drivers, emerging technologies, and competitive movements shaping the autoimmune treatment market from 2026–2035 with trusted insights from The Business Research Company
What total market size is anticipated for the Autoimmune Treatment Market in 2030?
The autoimmune treatment market size has seen swift expansion in recent years. It is anticipated to increase from $8.63 billion in 2025 to $9.84 billion in 2026, achieving a compound annual growth rate (CAGR) of 14.0%. The surge observed in the past can be attributed to the enhanced availability of immunosuppressive drugs, the expansion of rheumatology and immunology services, increasing clinical experience in autoimmune care, higher rates of patient diagnosis, and broader access to specialty medications.
The autoimmune treatment market size is projected for substantial expansion in the coming years. It is anticipated to reach $16.53 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 13.9%. This growth during the forecast period is attributable to several factors, including heightened investment in developing novel biologics, an increasing demand for tailored autoimmune therapies, the broadening of digital monitoring and follow-up care, a growing emphasis on minimizing long-term disease complications, and expanded research into immune system modulation. Key trends foreseen in the forecast period encompass a greater adoption of biologic therapies, an increased utilization of targeted immunomodulators, the expanding integration of long-term disease management initiatives, the proliferation of personalized treatment regimens, and an intensified focus on combination drug therapies.
Access Your Free Sample Report for In-Depth Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7863&type=smp
What Drivers Are Influencing Production Trends In The Autoimmune Treatment Market?
The growth of the autoimmune treatment market is expected to be driven by increasing healthcare expenditures. Healthcare expenditures encompass all expenses related to providing health services, family planning activities, nutrition programs, and emergency aid, with an emphasis on health. An increase in healthcare spending would lead to the development of more effective treatments and medical technologies for autoimmune conditions. For instance, according to the economic forecast from the Office for Budget Responsibility (OBR) and Treasury, the UK’s planned health expenditure is projected to increase to £192 billion ($244.43 billion) in 2024/25, up from £182 billion ($231.70 billion) in 2022/23. Similarly, the National Health Expenditures Accounts (NHEA) from KFF, a US-based independent health policy research organization, indicate that health spending in the United States is anticipated to grow by 5% from 2023 to 2024, reaching $4.9 trillion. Consequently, the expansion of healthcare expenditures is propelling the growth of the autoimmune treatment market.
Which Segment Groups Are Influencing The Autoimmune Treatment Market?
The autoimmune treatment market covered in this report is segmented –
1) By Service Type: Consultation And Diagnosis, Therapy And Monitoring, Drug development
2) By Disease: Rheumatoid Arthritis, Systemic Lupus Erythematosus, Sjögren’s Syndrome, Thyroiditis, Scleroderma, Other Diseases
3) By Application: Disease Management and Symptom Control, Disease Diagnosis and Monitoring, Immune Modulation and Targeted Therapy, Long-Term Care and Relapse Prevention
Subsegments:
1) By Consultation and Diagnosis: Clinical Evaluation and Medical Consultation, Autoimmune Biomarker Testing and Serological Assays, Imaging and Functional Diagnostic Services, Disease Severity Assessment and Risk Stratification
2) By Therapy and Monitoring: Pharmacological Treatment Management, Biologic and Immunotherapy Administration, Disease Activity Monitoring and Follow-Up Services, Adverse Event and Safety Monitoring, Patient Support and Adherence Programs
3) By Drug Development: Preclinical Research and Target Identification, Clinical Trial Services (Phase I–IV), Regulatory Affairs and Compliance Services, Pharmacovigilance and Post-Marketing Surveillance
Which Trends Are Influencing The Development Of The Autoimmune Treatment Market?
Major companies in the autoimmune treatment market are progressively concentrating on launching innovative clinical trial platforms to gain a competitive advantage. These advanced clinical trial platforms within autoimmune treatment utilize modern technologies and personalized methodologies to boost efficacy, safety, and patient outcomes. As an illustration, in August 2023, the Scleroderma Research Foundation, a US-based non-profit organization, unveiled the CONQUEST trial platform. The CONQUEST program is designed to propel research and treatments for scleroderma, a rare autoimmune disease impacting connective tissues, by tackling crucial clinical development challenges and fostering progress in scleroderma therapeutics. The CONQUEST platform clinical trial stands as the inaugural initiative of its kind in rare autoimmune diseases, engineered for the swift assessment of potential treatments for interstitial lung disease associated with systemic sclerosis (SSc-ILD) alongside global SSc outcomes, including those related to skin and other facets of the condition.
Who Are The Top-Performing Companies In The Autoimmune Treatment Market In Recent Years?
Major companies operating in the autoimmune treatment market are Abbott Laboratories, Amgen Inc., Eli Lilly and Company, Pfizer Inc., F Hoffmann-La Roche AG, AstraZeneca PLC, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Biogen Idec Inc., GSK PLC, Genentech Inc., AbbVie Inc., Celgene Corporation, Gilead Sciences Inc., Merck & Co. Inc., Novartis International AG, Sanofi SA, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., UCB SA, Alexion Pharmaceuticals Inc., AnaptysBio Inc., Apellis Pharmaceuticals Inc., Arena Pharmaceuticals Inc., Aurinia Pharmaceuticals Inc., BioCryst Pharmaceuticals Inc., Cabaletta Bio Inc., ChemoCentryx Inc., Corbus Pharmaceuticals Holdings Inc., CSL Limited
Access The Complete Report For Deeper Market Insights:
https://www.thebusinessresearchcompany.com/report/autoimmune-treatment-global-market-report
Which Region Currently Holds The Largest Share Of The Autoimmune Treatment Market?
North America was the largest region in the autoimmune treatment market in 2025. The regions covered in the autoimmune treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request Your Customized Autoimmune Treatment Market Research Report for Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=7863&type=smp
Browse Through More Reports Similar to the Global Autoimmune Treatment Market 2026, By The Business Research Company
Systemic Lupus Erythematosus Treatment Market Report 2026
Autoimmune Disease Diagnosis Market Report 2026
https://www.thebusinessresearchcompany.com/report/autoimmune-disease-diagnosis-global-market-report
Veterinary Autoimmune Disease Therapeutics Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
